Global Rare Endocrine Disease Treatment Market Size, Status and Forecast 2018-2025

Date: Sep 20 2018
|
QYRESEARCH
|
Number of Pages: 97
|
Alternate Text Alternate Text Alternate Text Alternate Text

This report focuses on the global Rare Endocrine Disease Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Rare Endocrine Disease Treatment development in United States, Europe and China.

The endocrine system is a chemical messenger system consisting of hormones, the group of glands of an organism that carry those hormones directly into the circulatory system to be carried towards distant target organs and the feedback loops of homeostasis that the hormones drive.
The rare endocrine disease treatment market is expected to grow rapidly over the forecast period owing to the increasing prevalence of rare endocrine diseases.
In 2017, the global Rare Endocrine Disease Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2018-2025.

The key players covered in this study
Novartis
Ipsen
Pfizer
Teva
EMD Serono
Novo Nordisk
Eli Lilly
Shire
Amgen
Corcept Therapeutics
Novelion Therapeutics

Market segment by Type, the product can be split into
Biologics
Organic Compounds

Market segment by Application, split into
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Rare Endocrine Disease Treatment status, future forecast, growth opportunity, key market and key players.
To present the Rare Endocrine Disease Treatment development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Rare Endocrine Disease Treatment are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


Table of Contents
1 Report Overview
    1.1 Study Scope
    1.2 Key Market Segments
    1.3 Players Covered
    1.4 Market Analysis by Type
           1.4.1 Global Rare Endocrine Disease Treatment Market Size Growth Rate by Type (2013-2025)
           1.4.2 Biologics
           1.4.3 Organic Compounds
    1.5 Market by Application
           1.5.1 Global Rare Endocrine Disease Treatment Market Share by Application (2013-2025)
           1.5.2 Hospital Pharmacies
           1.5.3 Online Pharmacies
           1.5.4 Retail Pharmacies
    1.6 Study Objectives
    1.7 Years Considered
2 Global Growth Trends
    2.1 Rare Endocrine Disease Treatment Market Size
    2.2 Rare Endocrine Disease Treatment Growth Trends by Regions
           2.2.1 Rare Endocrine Disease Treatment Market Size by Regions (2013-2025)
           2.2.2 Rare Endocrine Disease Treatment Market Share by Regions (2013-2018)
    2.3 Industry Trends
           2.3.1 Market Top Trends
           2.3.2 Market Drivers
           2.3.3 Market Opportunities
3 Market Share by Key Players
    3.1 Rare Endocrine Disease Treatment Market Size by Manufacturers
           3.1.1 Global Rare Endocrine Disease Treatment Revenue by Manufacturers (2013-2018)
           3.1.2 Global Rare Endocrine Disease Treatment Revenue Market Share by Manufacturers (2013-2018)
           3.1.3 Global Rare Endocrine Disease Treatment Market Concentration Ratio (CR5 and HHI)
    3.2 Rare Endocrine Disease Treatment Key Players Head office and Area Served
    3.3 Key Players Rare Endocrine Disease Treatment Product/Solution/Service
    3.4 Date of Enter into Rare Endocrine Disease Treatment Market
    3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
    4.1 Global Rare Endocrine Disease Treatment Market Size by Type (2013-2018)
    4.2 Global Rare Endocrine Disease Treatment Market Size by Application (2013-2018)
5 United States
    5.1 United States Rare Endocrine Disease Treatment Market Size (2013-2018)
    5.2 Rare Endocrine Disease Treatment Key Players in United States
    5.3 United States Rare Endocrine Disease Treatment Market Size by Type
    5.4 United States Rare Endocrine Disease Treatment Market Size by Application
6 Europe
    6.1 Europe Rare Endocrine Disease Treatment Market Size (2013-2018)
    6.2 Rare Endocrine Disease Treatment Key Players in Europe
    6.3 Europe Rare Endocrine Disease Treatment Market Size by Type
    6.4 Europe Rare Endocrine Disease Treatment Market Size by Application
7 China
    7.1 China Rare Endocrine Disease Treatment Market Size (2013-2018)
    7.2 Rare Endocrine Disease Treatment Key Players in China
    7.3 China Rare Endocrine Disease Treatment Market Size by Type
    7.4 China Rare Endocrine Disease Treatment Market Size by Application
8 Japan
    8.1 Japan Rare Endocrine Disease Treatment Market Size (2013-2018)
    8.2 Rare Endocrine Disease Treatment Key Players in Japan
    8.3 Japan Rare Endocrine Disease Treatment Market Size by Type
    8.4 Japan Rare Endocrine Disease Treatment Market Size by Application
9 Southeast Asia
    9.1 Southeast Asia Rare Endocrine Disease Treatment Market Size (2013-2018)
    9.2 Rare Endocrine Disease Treatment Key Players in Southeast Asia
    9.3 Southeast Asia Rare Endocrine Disease Treatment Market Size by Type
    9.4 Southeast Asia Rare Endocrine Disease Treatment Market Size by Application
10 India
    10.1 India Rare Endocrine Disease Treatment Market Size (2013-2018)
    10.2 Rare Endocrine Disease Treatment Key Players in India
    10.3 India Rare Endocrine Disease Treatment Market Size by Type
    10.4 India Rare Endocrine Disease Treatment Market Size by Application
11 Central & South America
    11.1 Central & South America Rare Endocrine Disease Treatment Market Size (2013-2018)
    11.2 Rare Endocrine Disease Treatment Key Players in Central & South America
    11.3 Central & South America Rare Endocrine Disease Treatment Market Size by Type
    11.4 Central & South America Rare Endocrine Disease Treatment Market Size by Application
12 International Players Profiles
    12.1 Novartis
           12.1.1 Novartis Company Details
           12.1.2 Company Description and Business Overview
           12.1.3 Rare Endocrine Disease Treatment Introduction
           12.1.4 Novartis Revenue in Rare Endocrine Disease Treatment Business (2013-2018)
           12.1.5 Novartis Recent Development
    12.2 Ipsen
           12.2.1 Ipsen Company Details
           12.2.2 Company Description and Business Overview
           12.2.3 Rare Endocrine Disease Treatment Introduction
           12.2.4 Ipsen Revenue in Rare Endocrine Disease Treatment Business (2013-2018)
           12.2.5 Ipsen Recent Development
    12.3 Pfizer
           12.3.1 Pfizer Company Details
           12.3.2 Company Description and Business Overview
           12.3.3 Rare Endocrine Disease Treatment Introduction
           12.3.4 Pfizer Revenue in Rare Endocrine Disease Treatment Business (2013-2018)
           12.3.5 Pfizer Recent Development
    12.4 Teva
           12.4.1 Teva Company Details
           12.4.2 Company Description and Business Overview
           12.4.3 Rare Endocrine Disease Treatment Introduction
           12.4.4 Teva Revenue in Rare Endocrine Disease Treatment Business (2013-2018)
           12.4.5 Teva Recent Development
    12.5 EMD Serono
           12.5.1 EMD Serono Company Details
           12.5.2 Company Description and Business Overview
           12.5.3 Rare Endocrine Disease Treatment Introduction
           12.5.4 EMD Serono Revenue in Rare Endocrine Disease Treatment Business (2013-2018)
           12.5.5 EMD Serono Recent Development
    12.6 Novo Nordisk
           12.6.1 Novo Nordisk Company Details
           12.6.2 Company Description and Business Overview
           12.6.3 Rare Endocrine Disease Treatment Introduction
           12.6.4 Novo Nordisk Revenue in Rare Endocrine Disease Treatment Business (2013-2018)
           12.6.5 Novo Nordisk Recent Development
    12.7 Eli Lilly
           12.7.1 Eli Lilly Company Details
           12.7.2 Company Description and Business Overview
           12.7.3 Rare Endocrine Disease Treatment Introduction
           12.7.4 Eli Lilly Revenue in Rare Endocrine Disease Treatment Business (2013-2018)
           12.7.5 Eli Lilly Recent Development
    12.8 Shire
           12.8.1 Shire Company Details
           12.8.2 Company Description and Business Overview
           12.8.3 Rare Endocrine Disease Treatment Introduction
           12.8.4 Shire Revenue in Rare Endocrine Disease Treatment Business (2013-2018)
           12.8.5 Shire Recent Development
    12.9 Amgen
           12.9.1 Amgen Company Details
           12.9.2 Company Description and Business Overview
           12.9.3 Rare Endocrine Disease Treatment Introduction
           12.9.4 Amgen Revenue in Rare Endocrine Disease Treatment Business (2013-2018)
           12.9.5 Amgen Recent Development
    12.10 Corcept Therapeutics
           12.10.1 Corcept Therapeutics Company Details
           12.10.2 Company Description and Business Overview
           12.10.3 Rare Endocrine Disease Treatment Introduction
           12.10.4 Corcept Therapeutics Revenue in Rare Endocrine Disease Treatment Business (2013-2018)
           12.10.5 Corcept Therapeutics Recent Development
    12.11 Novelion Therapeutics
13 Market Forecast 2018-2025
    13.1 Market Size Forecast by Regions
    13.2 United States
    13.3 Europe
    13.4 China
    13.5 Japan
    13.6 Southeast Asia
    13.7 India
    13.8 Central & South America
    13.9 Market Size Forecast by Product (2018-2025)
    13.10 Market Size Forecast by Application (2018-2025)
14 Analyst's Viewpoints/Conclusions
15 Appendix
    15.1 Research Methodology
           15.1.1 Methodology/Research Approach
                 15.1.1.1 Research Programs/Design
                 15.1.1.2 Market Size Estimation
                 12.1.1.3 Market Breakdown and Data Triangulation
           15.1.2 Data Source
                 15.1.2.1 Secondary Sources
                 15.1.2.2 Primary Sources
    15.2 Disclaimer
    15.3 Author Details

List of Tables and Figures
Table Rare Endocrine Disease Treatment Key Market Segments
Table Key Players Rare Endocrine Disease Treatment Covered
Table Global Rare Endocrine Disease Treatment Market Size Growth Rate by Type 2013-2025 (Million US$)
Figure Global Rare Endocrine Disease Treatment Market Size Market Share by Type 2013-2025
Figure Biologics Figures
Table Key Players of Biologics
Figure Organic Compounds Figures
Table Key Players of Organic Compounds
Table Global Rare Endocrine Disease Treatment Market Size Growth by Application 2013-2025 (Million US$)
Figure Hospital Pharmacies Case Studies
Figure Online Pharmacies Case Studies
Figure Retail Pharmacies Case Studies
Figure Rare Endocrine Disease Treatment Report Years Considered
Table Global Rare Endocrine Disease Treatment Market Size 2013-2025 (Million US$)
Figure Global Rare Endocrine Disease Treatment Market Size and Growth Rate 2013-2025 (Million US$)
Table Global Rare Endocrine Disease Treatment Market Size by Regions 2013-2025 (Million US$)
Table Global Rare Endocrine Disease Treatment Market Size by Regions 2013-2018 (Million US$)
Table Global Rare Endocrine Disease Treatment Market Share by Regions 2013-2018
Figure Global Rare Endocrine Disease Treatment Market Share by Regions 2013-2018
Figure Global Rare Endocrine Disease Treatment Market Share by Regions 2018
Table Market Top Trends
Table Global Rare Endocrine Disease Treatment Revenue by Manufacturers (2013-2018) (Million US$)
Table Global Rare Endocrine Disease Treatment Market Share by Manufacturers (2013-2018)
Figure Global Rare Endocrine Disease Treatment Market Share by Manufacturers in 2018
Table Global Rare Endocrine Disease Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Rare Endocrine Disease Treatment Product/Solution/Service
Table Date of Enter into Rare Endocrine Disease Treatment Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Rare Endocrine Disease Treatment Market Size by Type (2013-2018) (Million US$)
Table Global Rare Endocrine Disease Treatment Market Size Share by Type (2013-2018)
Figure Global Rare Endocrine Disease Treatment Market Size Market Share by Type (2013-2018)
Table Global Rare Endocrine Disease Treatment Market Size by Application (2013-2018) (Million US$)
Table Global Rare Endocrine Disease Treatment Market Size Share by Application (2013-2018)
Figure Global Rare Endocrine Disease Treatment Market Size Market Share by Application (2013-2018)
Figure Global Rare Endocrine Disease Treatment Revenue Market Share by Application in 2017
Figure United States Rare Endocrine Disease Treatment Market Size 2013-2018 (Million US$)
Table United States Key Players Rare Endocrine Disease Treatment Revenue (2017-2018) (Million US$)
Table United States Key Players Rare Endocrine Disease Treatment Market Share (2017-2018)
Table United States Rare Endocrine Disease Treatment Market Size by Type (2013-2018) (Million US$)
Table United States Rare Endocrine Disease Treatment Market Share by Type (2013-2018)
Table United States Rare Endocrine Disease Treatment Market Size by Application (2013-2018) (Million US$)
Table United States Rare Endocrine Disease Treatment Market Share by Application (2013-2018)
Figure Europe Rare Endocrine Disease Treatment Market Size 2013-2018 (Million US$)
Table Europe Key Players Rare Endocrine Disease Treatment Revenue (2017-2018) (Million US$)
Table Europe Key Players Rare Endocrine Disease Treatment Market Share (2017-2018)
Table Europe Rare Endocrine Disease Treatment Market Size by Type (2013-2018) (Million US$)
Table Europe Rare Endocrine Disease Treatment Market Share by Type (2013-2018)
Table Europe Rare Endocrine Disease Treatment Market Size by Application (2013-2018) (Million US$)
Table Europe Rare Endocrine Disease Treatment Market Share by Application (2013-2018)
Figure China Rare Endocrine Disease Treatment Market Size 2013-2018 (Million US$)
Table China Key Players Rare Endocrine Disease Treatment Revenue (2017-2018) (Million US$)
Table China Key Players Rare Endocrine Disease Treatment Market Share (2017-2018)
Table China Rare Endocrine Disease Treatment Market Size by Type (2013-2018) (Million US$)
Table China Rare Endocrine Disease Treatment Market Share by Type (2013-2018)
Table China Rare Endocrine Disease Treatment Market Size by Application (2013-2018) (Million US$)
Table China Rare Endocrine Disease Treatment Market Share by Application (2013-2018)
Figure Japan Rare Endocrine Disease Treatment Market Size 2013-2018 (Million US$)
Table Japan Key Players Rare Endocrine Disease Treatment Revenue (2017-2018) (Million US$)
Table Japan Key Players Rare Endocrine Disease Treatment Market Share (2017-2018)
Table Japan Rare Endocrine Disease Treatment Market Size by Type (2013-2018) (Million US$)
Table Japan Rare Endocrine Disease Treatment Market Share by Type (2013-2018)
Table Japan Rare Endocrine Disease Treatment Market Size by Application (2013-2018) (Million US$)
Table Japan Rare Endocrine Disease Treatment Market Share by Application (2013-2018)
Figure Southeast Asia Rare Endocrine Disease Treatment Market Size 2013-2018 (Million US$)
Table Southeast Asia Key Players Rare Endocrine Disease Treatment Revenue (2017-2018) (Million US$)
Table Southeast Asia Key Players Rare Endocrine Disease Treatment Market Share (2017-2018)
Table Southeast Asia Rare Endocrine Disease Treatment Market Size by Type (2013-2018) (Million US$)
Table Southeast Asia Rare Endocrine Disease Treatment Market Share by Type (2013-2018)
Table Southeast Asia Rare Endocrine Disease Treatment Market Size by Application (2013-2018) (Million US$)
Table Southeast Asia Rare Endocrine Disease Treatment Market Share by Application (2013-2018)
Figure India Rare Endocrine Disease Treatment Market Size 2013-2018 (Million US$)
Table India Key Players Rare Endocrine Disease Treatment Revenue (2017-2018) (Million US$)
Table India Key Players Rare Endocrine Disease Treatment Market Share (2017-2018)
Table India Rare Endocrine Disease Treatment Market Size by Type (2013-2018) (Million US$)
Table India Rare Endocrine Disease Treatment Market Share by Type (2013-2018)
Table India Rare Endocrine Disease Treatment Market Size by Application (2013-2018) (Million US$)
Table India Rare Endocrine Disease Treatment Market Share by Application (2013-2018)
Figure Central & South America Rare Endocrine Disease Treatment Market Size 2013-2018 (Million US$)
Table Central & South America Key Players Rare Endocrine Disease Treatment Revenue (2017-2018) (Million US$)
Table Central & South America Key Players Rare Endocrine Disease Treatment Market Share (2017-2018)
Table Central & South America Rare Endocrine Disease Treatment Market Size by Type (2013-2018) (Million US$)
Table Central & South America Rare Endocrine Disease Treatment Market Share by Type (2013-2018)
Table Central & South America Rare Endocrine Disease Treatment Market Size by Application (2013-2018) (Million US$)
Table Central & South America Rare Endocrine Disease Treatment Market Share by Application (2013-2018)
Table Novartis Company Details
Table Novartis Revenue in Rare Endocrine Disease Treatment Business (2013-2018) (Million US$)
Figure Novartis Revenue Growth Rate in Rare Endocrine Disease Treatment Business (2013-2018)
Table Novartis Recent Development
Table Ipsen Company Details
Table Ipsen Revenue in Rare Endocrine Disease Treatment Business (2013-2018)(Million US$)
Figure Ipsen Revenue Growth Rate in Rare Endocrine Disease Treatment Business (2013-2018)
Table Ipsen Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Rare Endocrine Disease Treatment Business (2013-2018)(Million US$)
Figure Pfizer Revenue Growth Rate in Rare Endocrine Disease Treatment Business (2013-2018)
Table Pfizer Recent Development
Table Teva Company Details
Table Teva Revenue in Rare Endocrine Disease Treatment Business (2013-2018)(Million US$)
Figure Teva Revenue Growth Rate in Rare Endocrine Disease Treatment Business (2013-2018)
Table Teva Recent Development
Table EMD Serono Company Details
Table EMD Serono Revenue in Rare Endocrine Disease Treatment Business (2013-2018)(Million US$)
Figure EMD Serono Revenue Growth Rate in Rare Endocrine Disease Treatment Business (2013-2018)
Table EMD Serono Recent Development
Table Novo Nordisk Company Details
Table Novo Nordisk Revenue in Rare Endocrine Disease Treatment Business (2013-2018)(Million US$)
Figure Novo Nordisk Revenue Growth Rate in Rare Endocrine Disease Treatment Business (2013-2018)
Table Novo Nordisk Recent Development
Table Eli Lilly Company Details
Table Eli Lilly Revenue in Rare Endocrine Disease Treatment Business (2013-2018)(Million US$)
Figure Eli Lilly Revenue Growth Rate in Rare Endocrine Disease Treatment Business (2013-2018)
Table Eli Lilly Recent Development
Table Shire Company Details
Table Shire Revenue in Rare Endocrine Disease Treatment Business (2013-2018)(Million US$)
Figure Shire Revenue Growth Rate in Rare Endocrine Disease Treatment Business (2013-2018)
Table Shire Recent Development
Table Amgen Company Details
Table Amgen Revenue in Rare Endocrine Disease Treatment Business (2013-2018)(Million US$)
Figure Amgen Revenue Growth Rate in Rare Endocrine Disease Treatment Business (2013-2018)
Table Amgen Recent Development
Table Corcept Therapeutics Company Details
Table Corcept Therapeutics Revenue in Rare Endocrine Disease Treatment Business (2013-2018)(Million US$)
Figure Corcept Therapeutics Revenue Growth Rate in Rare Endocrine Disease Treatment Business (2013-2018)
Table Corcept Therapeutics Recent Development
Table Novelion Therapeutics Company Details
Table Global Rare Endocrine Disease Treatment Market Size by Regions (Million US$) 2018-2025
Figure Global Rare Endocrine Disease Treatment Market Size Share by Regions (2018-2025)
Figure Global Rare Endocrine Disease Treatment Market Size Share by Regions in 2025
Figure United States Rare Endocrine Disease Treatment Market Size Forecast (2018-2025)(Million USD)
Figure Europe Rare Endocrine Disease Treatment Market Size Forecast (2018-2025)(Million USD)
Figure China Rare Endocrine Disease Treatment Market Size Forecast (2018-2025)(Million USD)
Figure Japan Rare Endocrine Disease Treatment Market Size Forecast (2018-2025)(Million USD)
Figure Southeast Asia Rare Endocrine Disease Treatment Market Size Forecast (2018-2025)(Million USD)
Figure India Rare Endocrine Disease Treatment Market Size Forecast (2018-2025)(Million USD)
Figure Central & South America Rare Endocrine Disease Treatment Market Size Forecast (2018-2025)(Million USD)
Table Global Rare Endocrine Disease Treatment Market Size by Product (2018-2025) (Million US$)
Figure Global Rare Endocrine Disease Treatment Market Size by Product (2018-2025)
Figure Global Rare Endocrine Disease Treatment Market Size by Product in 2025
Table Global Rare Endocrine Disease Treatment Market Size by Application (2018-2025) (Million US$)
Figure Global Rare Endocrine Disease Treatment Market Size by Application (2018-2025)
Figure Global Rare Endocrine Disease Treatment Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Electronic files(PDF) of market research reports will be dispatched within 12 to 24 hours. (Mon-Fri IST)

Select License Type

Need Help?
+
SUBSCRIBE TO THE MAILING TO KEEP UP WITH LATEST NEWS AND UPDATES
x
We use cookies to deliver the best possible experience on our website by improving the user experience, personalizing your visit, and compiling aggregate statistics. By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more visit our Privacy policy page.